Organogenesis appoints Michele Korfin and Gilberto Quintero to board as independent directors

Organogenesis Holdings Inc.

Michele Korfin appointed as independent director; brings experience from Gamida Cell, Kite Pharma, Celgene.
Gilberto Quintero appointed as independent director; serves as Chief Quality Officer at Kimberly-Clark, formerly at Cardinal Health.
Each director receives $55,000 annual retainer and 23,913 RSUs vesting May 3, 2023.
Board expands to 11 members, with majority now independent under Nasdaq standards.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Gilberto Quintero

independent director

ORGO · Organogenesis Holdings Inc.

Effective: 2022-05-03
Filed: May 5, 2022, 7:59 PM ET

the Company announced that each of Michele I. Korfin and Gilberto Quintero had been appointed by the board of directors to serve as an independent director

Appointed

Michele I. Korfin

independent director

ORGO · Organogenesis Holdings Inc.

Effective: 2022-05-03
Filed: May 5, 2022, 7:59 PM ET

the Company announced that each of Michele I. Korfin and Gilberto Quintero had been appointed by the board of directors to serve as an independent director

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gilberto Quintero was appointed as independent director at Organogenesis Holdings Inc..

Action: appointed
Role: independent director

Exact text from the filing

the Company announced that each of Michele I. Korfin and Gilberto Quintero had been appointed by the board of directors to serve as an independent director

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michele I. Korfin was appointed as independent director at Organogenesis Holdings Inc..

Action: appointed
Role: independent director

Exact text from the filing

the Company announced that each of Michele I. Korfin and Gilberto Quintero had been appointed by the board of directors to serve as an independent director

View on SEC.gov

Organogenesis Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-142414

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.